Manufacturer record
Akums Drugs & Pharmaceuticals Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
13 batches manufactured by Akums Drugs & Pharmaceuticals Ltd (Uttarakhand) were declared Not of Standard Quality between January 2019 and April 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
13 records linked to Akums Drugs & Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Misoprostol Tablets IP 200 mcg | BGW02AAAMfg 2025-02 · Exp 2027-01 | The sample does not conform I.P with respect to the Assay of MisoprostolAssay | CDL, KolkataCDSCO lab | Apr 2026 |
| Diclofenac Sodium, Paracetamol and Chlorzoxazone Tablets | ZACF 2505Mfg 2025-07 · Exp 2027-06 | DescriptionDescription | DTL, JaipurState lab | Mar 2026 |
| Calcium and Vitamin D3 Tablets IP | BCB01AAAMfg 2025-01 · Exp 2026-12 | The sample does not conform to the IP with respect to Assay Vitamin D3Assay | DTL, JaipurState lab | Dec 2025 |
| Snikuf 4 | RZAB01Mfg 2023-05 · Exp 2025-04 | Sample does not conform to label claim with respect to the content of Terbutaline Sulphate.Labelling | DTL ChennaiState lab | Dec 2024 |
| Rabeprazole Tablets IP 20mg | PLO7AK04Mfg 2020-05 · Exp 2022-04 | DissolutionDissolution | RDTL GuwahatiState lab | Mar 2022 |
| MAYCOXIA-90 (Etoricoxib Tablets IP) | OBZB02Mfg 2021-07 · Exp 2023-06 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Mar 2022 |
| DICLOFENAC, VIRGIN LINSEED OIL, METHYL SALICYLATE AND MENTHOL GEL | JZAA02Mfg 2021-01 · Exp 2022-12 | Assay of MentholAssay | RDTL ChandigarhCDSCO lab | Oct 2021 |
| PANTOWEL - 40 (Pantoprazole Sodium Tablets I.P. 40 mg) | OBYA01Mfg 2020-02 · Exp 2022-07 | DissolutionDissolution | CDL KolkataCDSCO lab | Apr 2021 |
| Omnikacin ? 250 (Amikacin Injection I.P.) | C2VAR02Mfg 2020-01 · Exp 2021-12 | AssayAssay | CDL KolkataCDSCO lab | Jan 2021 |
| Fexcor-120 (Fexofenadine Hydrochloride Tablets I.P. 120 mg) | OBRP01Mfg 2019-08 · Exp 2021-07 | DescriptionDescription | CDL KolkataCDSCO lab | Jun 2020 |
| Ferrous Ascorbate, Folic Acid and Mecobalamin Suspension (Ferikind-M Suspension | A6APS006Mfg 2019-03 · Exp 2020-08 | Assay of Folic AcidAssay | RDTL ChandigarhCDSCO lab | Dec 2019 |
| OCONA-CT Scalp Solution (Coal Tar & Ketoconazole Solution) ? 50 ml | COAK89Mfg 2017-12 · Exp 2019-11 | Foreign MatterOther | CDL KolkataCDSCO lab | Apr 2019 |
| Linezolid Tablets IP | OBLI01Mfg 2018-03 · Exp 2020-02 | AssayAssay | CDTL MumbaiCDSCO lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.